Insomnia with Short Sleep Duration: Nosological, Diagnostic, and Treatment Implications
- PMID: 24072989
- PMCID: PMC3780422
- DOI: 10.1016/j.jsmc.2013.04.009
Insomnia with Short Sleep Duration: Nosological, Diagnostic, and Treatment Implications
Abstract
The diagnosis of insomnia is based solely on subjective complaints. This has contributed to the low reliability and validity of the current nosology of insomnia as well as to its lack of firm association with clinically relevant outcomes such as cardiometabolic and neurocognitive morbidity. We review evidence that insomnia with objective short sleep duration is associated with physiological hyperarousal, higher risk for hypertension, diabetes, neurocognitive impairment, and mortality as well as with a persistent course. It also appears that objective short sleep duration in poor sleepers is a biological marker of genetic predisposition to chronic insomnia. In contrast, insomnia with objective normal sleep duration is associated with cognitive-emotional and cortical arousal and sleep misperception but not with signs of physiological hyperarousal or medical complications. Thus, short sleep duration in insomnia may be a reliable marker of the biological severity and medical impact of the disorder. We propose that (a) objective measures of sleep be included in the diagnosis of insomnia and its subtypes, (b) objective measures of sleep obtained in the home environment of the patient would become part of the routine assessment and diagnosis of insomnia in a clinician's office setting, and (c) insomnia with short sleep duration may respond better to biological treatments, whereas insomnia with normal sleep duration may respond primarily to psychological therapies.
Keywords: Insomnia; cardiometabolic; morbidity; mortality; neurocognitive; physiological hyperarousal; short sleep duration.
Figures
Similar articles
-
Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.Sleep Med Rev. 2013 Aug;17(4):241-54. doi: 10.1016/j.smrv.2012.09.005. Epub 2013 Feb 16. Sleep Med Rev. 2013. PMID: 23419741 Free PMC article. Review.
-
Insomnia and its impact on physical and mental health.Curr Psychiatry Rep. 2013 Dec;15(12):418. doi: 10.1007/s11920-013-0418-8. Curr Psychiatry Rep. 2013. PMID: 24189774 Free PMC article. Review.
-
Neurocognitive performance in insomnia disorder: The impact of hyperarousal and short sleep duration.J Sleep Res. 2018 Dec;27(6):e12747. doi: 10.1111/jsr.12747. Epub 2018 Aug 1. J Sleep Res. 2018. PMID: 30069961
-
The insomnia with short sleep duration phenotype: an update on it's importance for health and prevention.Curr Opin Psychiatry. 2017 Jan;30(1):56-63. doi: 10.1097/YCO.0000000000000292. Curr Opin Psychiatry. 2017. PMID: 27764017 Review.
-
Insomnia with physiological hyperarousal is associated with hypertension.Hypertension. 2015 Mar;65(3):644-50. doi: 10.1161/HYPERTENSIONAHA.114.04604. Epub 2015 Jan 26. Hypertension. 2015. PMID: 25624338
Cited by
-
2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults - Brazilian Sleep Association.Sleep Sci. 2023 Nov 22;16(Suppl 2):507-549. doi: 10.1055/s-0043-1776281. eCollection 2023 Oct. Sleep Sci. 2023. PMID: 38370879 Free PMC article. Review.
-
Daytime autonomic nervous system functions differ among adults with and without insomnia symptoms.J Clin Sleep Med. 2023 Nov 1;19(11):1885-1893. doi: 10.5664/jcsm.10704. J Clin Sleep Med. 2023. PMID: 37421322
-
Animal models of human insomnia.J Sleep Res. 2023 Dec;32(6):e13845. doi: 10.1111/jsr.13845. Epub 2023 Feb 7. J Sleep Res. 2023. PMID: 36748845 Review.
-
A latent class approach to understanding longitudinal sleep health and the association with alcohol and cannabis use during late adolescence and emerging adulthood.Addict Behav. 2022 Nov;134:107417. doi: 10.1016/j.addbeh.2022.107417. Epub 2022 Jun 28. Addict Behav. 2022. PMID: 35853405 Free PMC article.
-
Association of insomnia and short sleep duration, alone or with comorbid obstructive sleep apnea, and the risk of chronic kidney disease.Sleep. 2022 Jul 11;45(7):zsac088. doi: 10.1093/sleep/zsac088. Sleep. 2022. PMID: 35445715 Free PMC article.
References
-
- Bixler EO, Vgontzas AN, Lin HM, Vela-Bueno A, Kales A. Insomnia in central Pennsylvania. J Psychosom Res. 2002;53(1):589–92. - PubMed
-
- Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111. - PubMed
-
- Morin CM, LeBlanc M, Daley M, Gregoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7:123–30. - PubMed
-
- National Institutes of Health NIH state of the science statement on manifestations and management of chronic insomnia in adults. J Clin Sleep Med. 2005;1:412–421. - PubMed
-
- Léger D, Bayon V. Societal costs of insomnia. Sleep Med Rev. 2010;14(6):379–89. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
